Hytrin 5 Tablet contains Terazosin 5 mg, an alpha-1 adrenergic receptor antagonist primarily indicated for the treatment of hypertension and benign prostatic hyperplasia (BPH). Terazosin works by selectively blocking alpha-1 receptors in vascular smooth muscle and the prostate, leading to vasodilation and relaxation of the bladder neck and prostate muscles. This dual mechanism results in improved urinary flow and reduced blood pressure. Hytrin 5 is typically administered once daily, with dosage adjustments based on therapeutic response and patient tolerance. It is important to initiate therapy at a low dose to minimize the risk of orthostatic hypotension and syncope, especially during the first dose. Common adverse effects include dizziness, headache, fatigue, and nasal congestion. Caution is advised in patients with a history of hypotension or those receiving concomitant antihypertensive therapy. Monitoring blood pressure and symptom relief is essential to optimize treatment outcomes. Hytrin 5 should be used under medical supervision, with consideration of contraindications such as hypersensitivity to Terazosin or related compounds. This medication is not intended for use in pediatric patients. Patients are advised to avoid abrupt discontinuation and to report any adverse reactions promptly to their healthcare provider.

Dosage & How to Use